GJA1 and glioma: Specifically, miR-5096 was identified to enhance the invasiveness of glioma cells in a Cx43-dependent manner, by using a combination of techniques that include the use of GJ inhibitors and an anti-miRTM that “neutralizes” the action of miR-5096 [25].